Editorial Board

Código QR

Editorial Board

Guardado en:

Detalles Bibliográficos
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/91bf80e362674fcb86dc0a8ae5bc1b6b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Editorial Board Page
Publicado: (2021)

Evolution of the Editorial Board Underpins a Commitment to Change and Innovation
por: Demosthenes G Katritsis
Publicado: (2020)

Heart healthy diet: A modifiable tool for cardiovascular disease prevention
por: Rama Hritani
Publicado: (2021)

Editors’ page
por: Erin D. Michos, et al.
Publicado: (2021)

Association between diet quality and incident cardiovascular disease stratified by body mass index
por: Nathan W. Kong, et al.
Publicado: (2021)

DISPARITIES AMONG RACE AND GENDER IN SUSTAINED ACHIEVEMENT OF GOAL LIPID LEVELS AFTER ACUTE CORONARY SYNDROME
por: Maxwell Ambrosino, et al.
Publicado: (2021)

“DO NOT RESUSCITATE” ORDERS AMONG HOSPITALIZED PATIENTS WITH COVID-19: EVALUATING PREVENTIVE ETHICS REGARDING CARDIOPULMONARY RESUSCITATION
por: Johnathan Kirupakaran, et al.
Publicado: (2021)

IMPROVING PRIMARY CARE AWARENESS AND SCREENING OF ADULTS WITH FAMILIAL HYPERCHOLESTEROLEMIA THROUGH AN ONLINE PROVIDER EDUCATIONAL PROGRAM
por: Mary Nametka, et al.
Publicado: (2021)

NOVEL TIERED HEART FAILURE STAGING, RISK, AND SOCIAL DETERMINANTS OF HEALTH OF AN URBAN COMMUNITY CLINIC BEFORE AND DURING COVID-19
por: Melvin R. Echols, et al.
Publicado: (2021)

GENDER DOES NOT SIGNIFICANTLY MODULATE FASTING PLASMA GLUCOSE IMPROVEMENTS WITH LIFESTYLE INTERVENTION IN PREDIABETES PARTICIPANTS WITH VERSUS WITHOUT A FAMILY HISTORY OF DIABETES
por: Karen S. George, et al.
Publicado: (2021)

LIVRQNac (AXA1125) ENHANCES INSULIN SENSITIVITY IN PRIMARY HUMAN HEPATOCYTES AND IN SUBJECTS WITH NAFLD AND T2D
por: Seth J. Baum, et al.
Publicado: (2021)

ARE THERE DIFFERENCES IN STATIN PRESCRIBING PRACTICES BASED ON PROVIDER AND PATIENT GENDERS? A RETROSPECTIVE, QUANTITATIVE AND QUALITATIVE CHART REVIEW
por: Payton Skawinski, et al.
Publicado: (2021)

SERUM COPPER AND THE RISK OF CVD MORTALITY IN NORMAL WEIGHT, PRE-OBESE AND OBESE MEN IN FINLAND
por: Nzechukwu M. Isiozor, et al.
Publicado: (2021)

PERFORMANCE OF EXISTING CARDIOVASCULAR RISK ASSESSMENT TOOLS IN SUB-SAHARAN AFRICA: A SYSTEMATIC REVIEW
por: Yousif M. Hydoub, et al.
Publicado: (2021)

INCREASING STATIN USE IN DIABETICS FOR CVD PREVENTION
por: Karsh Gaurav, et al.
Publicado: (2021)

WHAT DRIVES PRIMARY CARE PROVIDERS TO SCREEN WOMEN VETERANS FOR CARDIOVASCULAR RISKS WITH COMPETING DEMANDS AND LIMITED TIME? PATIENT FACTORS ASSOCIATED WITH TEMPLATE USE IN THE VA
por: Bevanne Bean-Mayberry, et al.
Publicado: (2021)

ASPIRIN FOR CARDIOVASCULAR DISEASE PREVENTION AMONG ADULTS IN THE UNITED STATES: TRENDS, PREVALENCE, AND PARTICIPANT CHARACTERISTICS ASSOCIATED WITH USE
por: Ellen Boakye, et al.
Publicado: (2021)

DISPARITIES AMONG GENDER AND RACIAL GROUPS IN THE USE OF GUIDELINE DIRECTED HYPERLIPIDEMIA MANAGEMENT IN PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME
por: Maxwell Ambrosino, et al.
Publicado: (2021)

SUCCESSFUL PIVOT OF A COMMUNITY EXERCISE PROGRAM TO VIRTUAL DURING THE COVID-19 PANDEMIC
por: LeTracia Rose, et al.
Publicado: (2021)

ESTIMATED AGGREGATE TREATMENT BENEFIT WITH ADDITION OF MULTIPLE NOVEL MEDICATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
por: Robert W. Ariss, et al.
Publicado: (2021)

Table of Contents
Publicado: (2021)

INTERVENTIONS TO MITIGATE CARDIOVASCULAR DISEASE RISK AFTER ADVERSE PREGNANCY OUTCOMES: A REVIEW
por: Amanda R. Jowell, et al.
Publicado: (2021)

Title page
Publicado: (2021)

INTERNAL MEDICINE RESIDENT EDUCATION AND THE IMPACT ON CARDIAC REHABILITATION REFERRAL RATES IN AN AMBULATORY CARE SETTING: A PILOT STUDY
por: Maggie Wang, et al.
Publicado: (2021)

PROPORTION OF PSORIASIS IN FAMILIAL HYPERCHOLESTEROLEMIA
por: Samip Sheth, et al.
Publicado: (2021)

CLINICAL PROFILE AND OUTCOMES OF HOSPITALIZED PATIENTS WITH COVID-19 AND CARDIOMETABOLIC RISK FACTORS IN BROOKLYN, NEW YORK
por: Johnathan Kirupakaran, et al.
Publicado: (2021)

DETECTING HYPERTENSION AND IMPROVING HEALTHY LIFESTYLE IN AFRICAN AMERICAN WOMEN ATTENDING COMMUNITY SCREENING PROGRAM
por: Waddah Malas, et al.
Publicado: (2021)

Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006–2015
por: Victor Okunrintemi, et al.
Publicado: (2021)

Editorial: The EXCEL Trial
por: Pablo Avanzas, et al.
Publicado: (2021)

Association of Hypertension and Diabetes with Ischemic Heart Disease and Stroke Mortality in India: The Million Death Study
por: Calvin Ke, et al.
Publicado: (2021)

Income disparity and utilization of cardiovascular preventive care services among U.S. adults
por: Andi Shahu, et al.
Publicado: (2021)

The impact of lipid-lowering medications on coronary artery plaque characteristics
por: Vishnu Priya Pulipati, et al.
Publicado: (2021)

Infrastructure Availability for the Care of Congenital Heart Disease Patients and Its Influence on Case Volume, Complexity and Access Among Healthcare Institutions in 17 Middle-Income Countries
por: Isaac Wamala, et al.
Publicado: (2021)

Paclitaxel- and Sirolimus-coated Balloons in Peripheral Artery Disease Treatment: Current Perspectives and Concerns
por: Masayuki Mori, et al.
Publicado: (2021)

Comment on ‘Management of Cardiac Sarcoidosis in 2020’
por: Socrates Korovesis, et al.
Publicado: (2021)

Coronavirus Disease 2019: Cardiac Complications and Considerations for Returning to Sports Participation
por: Daniel X Augustine, et al.
Publicado: (2021)

Impact of the Pattern of Atrial Fibrillation on Stroke Risk and Mortality
por: Giovanni Luca Botto, et al.
Publicado: (2021)

Current Evidence and Future Directions of PCSK9 Inhibition
por: Jiaqian Xu, et al.
Publicado: (2021)

Pulmonary Embolism and Heart Failure: A Reappraisal
por: Mattia Arrigo, et al.
Publicado: (2021)

The EXCEL Trial: The Interventionalists’ Perspective
por: George William Hunter, et al.
Publicado: (2021)